TELA Bio, Inc. (TELA)

TELA Bio Stock Forecast

Stock Price Forecast

The 4 analysts that cover TELA Bio stock have a consensus rating of "Strong Buy" and an average price target of $6.00, which forecasts a 224.32% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $8.00.

Price Target: $6.00 (+224.32%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.00	$6.00	$7.00	$8.00
Change	+8.11%	+224.32%	+278.38%	+332.43%

* Price targets were last updated on Mar 21, 2025.

Analyst Ratings

The average analyst rating for TELA Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Caitlin Cronin Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $12 → $7	Strong Buy	Maintains	$12 → $7	+278.38%	Mar 21, 2025
David Turkaly Citizens Capital Markets	Citizens Capital Markets	Buy Maintains $12 → $7	Buy	Maintains	$12 → $7	+278.38%	Mar 21, 2025
Matt O'Brien Piper Sandler	Piper Sandler	Buy → Hold Downgrades $5 → $2	Buy → Hold	Downgrades	$5 → $2	+8.11%	Mar 21, 2025
Matt O'Brien Piper Sandler	Piper Sandler	Buy Maintains $8 → $5	Buy	Maintains	$8 → $5	+170.27%	Nov 8, 2024
Caitlin Cronin Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $12	Strong Buy	Maintains	$12	+548.65%	Oct 4, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

87.78M

Increased by 26.67%

from 69.30M

Revenue Next Year

107.65M

Increased by 22.63%

from 87.78M

EPS This Year

-0.73

from -1.33

EPS Next Year

-0.42

from -0.73

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	18.21M	29.46M	41.42M	58.45M	69.30M	87.78M	107.65M	130.64M
Revenue Growth	17.91%	61.77%	40.58%	41.13%	18.56%	26.67%	22.63%	21.36%
EPS	-2.23	-2.30	-2.72	-2.04	-1.33	-0.73	-0.42	0.12
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	15.77
No. Analysts	-	-	-	-	-	7	7	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	90.9M	115.6M	141.8M
Avg	87.8M	107.7M	130.6M
Low	83.3M	99.6M	118.7M

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	31.2%	31.7%	31.7%
Avg	26.7%	22.6%	21.4%
Low	20.2%	13.4%	10.2%

EPS Forecast

EPS	2025	2026	2027	2028
High	-0.65	-0.20	0.22
Avg	-0.73	-0.42	0.12
Low	-0.74	-0.56	0.02

EPS Growth

EPS Growth	2025	2026	2027	2028
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.